| JNTL Consumer Health II (Switzerland) GmbH - Nicorette Invisi 10 mg/16 h, transdermales Pflaster |
| 58175 | | 01 | | Nicorette Invisi 10 mg/16 h | | transdermales Pflaster | | N07BA01 | | Nicotine | | 17.09.2009 | | |
|
| Composition |
| nicotinum 15.75 mg, triglycerida media, copolymerum methacrylatis butylati basicum, 2-ethylhexylacrylate/butyracryltate/vinylacetate/acrylic acid Copolymer (75:15:5:5) in ethylacetate/heptane (85:15), kalii hydroxidum, carmellosum natricum conexum, aluminii acetylacetonas pro praeparatione cum liberatione 10 mg/16h. |
| Packungsbestandteile |
| Transdermal System | | | | | | Active Agent | Dose |
|---|
| Nicotine | 15.75 mg |
| | | | Inactive agents |
|---|
| 2-ethylhexylacrylate/butyracryltate/vinylacetate/acrylic acid Copolymer (75:15:5:5) in Ethylacetate/heptane (85:15) | | Aluminii Acetylacetonas | | Carmellosum Natricum Conexum | | Copolymerum Methacrylatis Butylati Basicum | | Kalii Hydroxidum | | Triglycerida Media |
|
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 002 | 14 plaster(s) | PR | PR | D | | Yes |
|
